Global Fund Moves To Discontinue Project Subsidizing Malaria Drugs | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Global Fund Moves To Discontinue Project Subsidizing Malaria Drugs

One of the world's largest health funding agencies — the Global Fund — made two big decisions Thursday.

The fund appointed Dr. Mark Dybul as its new executive director. Dybul is best known for leading the international fight against HIV during the Bush's administration through the President's Emergency Plan For AIDS.

The fund's board also decided the fate of a controversial $225 million project that subsidizes the cost of the most effective malaria drugs in Africa.

The fund says it will discontinue financial support for the Affordable Medicines Facility-malaria program, or AMFm, after a one-year transition period. Countries that wish to continue using subsidies will have to divert money from their regular malaria work to pay for them.

There has been a vigorous debate in the global health community about AMFm.

Advocates, such as Barry Bloom of Harvard School of Public Health, say the pilot project has reached its major goal. It's gotten the best malaria drugs to more people by reducing their cost through collective bargaining and payments to manufacturers.

Critics, on the other hand, claim that AMFm is wasteful. They say the program has put the drugs in the hands of the untrained people, such as shopkeepers and private pharmacists who've given the drugs to people even when they don't have malaria. One study even reported a gross overtreatment of malaria in many countries participating in the AMFm.

Here's how the Global Fund describes plans for the project:

During a transition period in 2013, the lessons learned from the operations and resourcing of Phase 1 of the AMFm, such as manufacturer negotiations and the co-payment mechanism, will be integrated into core Global Fund processes.... Under the new, integrated model, eligible countries will be able to allocate funding from their core Global Fund grants and determine how the money should be spent.

"This raises an awful lot of worries," Bloom tells Shots. "I'm concerned that its decision is more determined by politics and ideology than a focus on how to deal with kids and adults with fevers in poor countries."

Bloom says it's unclear if each country now has to bargain with drug manufacturers on its own, and thus will lose their collective bargaining power to keep the price of malaria drugs low.

He also says the Global Fund didn't address a major problem with malaria in Africa — diagnosing it properly before beginning treatment. "I had hoped that the Global Fund would create a pilot project for linking diagnosis to treatments," he says. "They could have done a lot better."

Earlier this week, Stanford University economist and Nobel laureate Kenneth Arrow, also voiced his support for AMFm in The New York Times. "This initiative is an interim measure to ensure that fewer children die for lack of effective anti-malarials," he wrote. "The risk is that efforts to develop and implement "the perfect" will end up killing 'the good' in the process."

Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.

NPR

Jenner: 'For All Intents And Purposes, I Am A Woman'

In an interview with Diane Sawyer on ABC's "20/20", the former gold-medal-winning Olympic decathlete described a struggle with gender identity that began in childhood.
NPR

PepsiCo Swaps Diet Drink's Aspartame For Other Artificial Sweeteners

The company says Diet Pepsi consumers are concerned about aspartame. But the Food and Drug Administration has long affirmed that the sweetener is safe in amounts commonly used by beverage companies.
NPR

Week In Politics: Clinton Foundation, Drone Strikes

NPR's Melissa Block talks with E.J. Dionne of the Washington Post and Brookings Institution and David Brooks of The New York Times about the Clinton Foundation financial news and drone strikes.
NPR

At The Heart Of A Watch, Tested By Time

Watchmakers have long thrived by selling timepieces that will be cherished as family heirlooms. But, if pragmatism rendered the pocket watch obsolete, what happens when watches become computers?

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.